Purchase Order HHSN268201600391PC

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $33,560 purchase order to Antibodies Incorporated for two monoclonal antibody projects. Antibodies Incorporated, doing business as Antibodies Inc., will deliver the requested monoclonal antibodies from its Bethesda, Maryland facility within the one-month period of performance ending September 30, 2023. As the prime contractor, Antibodies Inc. will be responsible for completion of the two...

This federal contract award, valued at $91,556.85, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Research And Diagnostic Systems, Inc. (R&D Systems), a subsidiary of Bio-Techne Corporation. The contract is for the supply of various antibodies, with no set-aside designation. R&D Systems is a manufacturer of high-quality research reagents and instruments, including antibodies, ELISA kits, and recombinant...

This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), to Pacific Immunology, a USA-based biotech company located in Ramona, California. The contract is for the production of monospecific antibodies, with a ceiling value of $4,321.60 and an ultimate completion date of March 10, 2010. The contract does not utilize a set-aside designation. Pacific Immunology, the prime...

The U.S. Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a firm-fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to generate drug-specific monoclonal antibodies against TTHX1114, an engineered mutant human FGF1. The $50,208.55 contract has a completion date of June 30, 2020 and does not have a set-aside designation. Precision Antibody is a for-profit...

The National Institute of Standards and Technology (NIST) awarded a $500,000 firm fixed-price purchase order to Sigma-Aldrich, Inc., doing business as Sigma-Aldrich Sales, Inc., for the manufacturing of a monoclonal antibody expressed from the NISTCHO cell line. The contract has no set-aside designation and is expected to be completed by August 5, 2026. Sigma-Aldrich, a foreign-owned, for-profit organization, will deliver the monoclonal antibody at a concentration of 100 mg/mL in L-Histidine....

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order valued at $21,863.25 to Biolegend, Inc. for BIOLEGEND TOTALSEQ ANTIBODIES. No set-aside designation was used. Performance will occur in San Diego, California with a completion date of May 7, 2024. Biolegend, Inc. is a subsidiary of Revvity Inc.'s Medical Imaging, LLC division. The award is likely associated with research efforts...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Research And Diagnostic Systems, Inc. (R&D Systems) for the delivery of antibodies. The $3,145.50 firm fixed-price purchase order did not have a set-aside designation. R&D Systems is a subsidiary of Bio-Techne Corporation, a major provider of life sciences research tools and reagents, which has been awarded numerous...

Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, has been awarded a $22,064 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide clinical assays of mouse anti-human immunoglobulin G1 under NIAID's AMBIS blanket purchase agreement number 2179527. The assays will support NIAID's infectious disease research programs and will be delivered from Life...

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...

This is a $5,260.00 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to R&D Systems, Inc. for the acquisition of antibodies. The award does not have a set-aside designation. R&D Systems is a manufacturer and supplier of research reagents and instruments, and a subsidiary of the parent company Bio-Techne Corporation. The contract supports biomedical research at NIAID by providing critical laboratory materials such as...